United States Point-Of-Care Infectious Disease Diagnostics Market was valued at USD 1.8 Billion in 2022 and is projected to reach USD 3.4 Billion by 2030, growing at a CAGR of 8.7% from 2024 to 2030.
The U.S. Point-Of-Care (Poc) Infectious Disease Diagnostics Market Has Experienced Significant Growth, Driven By Technological Advancements And The Increasing Demand For Rapid, Accurate Testing Solutions. CiteTurn0Search3 This Expansion Has Led To A Diverse Range Of Diagnostic Methods And Evolving Industry Requirements.
**Diverse Diagnostic Technologies**
Several Diagnostic Technologies Have Become Prominent In The Poc Infectious Disease Testing Landscape:
Molecular Diagnostics: Accounting For Approximately 43% Of The Market Share In 2023, Molecular Diagnostics Are Valued For Their High Accuracy In Detecting Genetic Material Of Pathogens. These Tests Provide Rapid And Precise Results, Essential For Timely Patient Care. CiteTurn0Search3
Lateral Flow Immunoassays: Known For Their Portability And Ease Of Use, These Assays Are Ideal For Settings Like Homes And Remote Healthcare Facilities. They Enable Quick Detection Of Infectious Agents, Contributing To Their Growing Adoption. CiteTurn0Search3
Multiplex Testing: The Trend Toward Multiplex Testing Allows Simultaneous Detection Of Multiple Pathogens From A Single Sample, Offering Comprehensive Diagnostic Information Swiftly. CiteTurn0Search2
**Industry Requirements And Trends**
The Poc Diagnostics Industry Is Adapting To Meet Various Evolving Needs:
Regulatory Landscape: Proposed Plans To Enhance Federal Regulation Of Diagnostic Tests Aim To Ensure Accuracy And Reliability. However, Potential Policy Changes Could Impact The Implementation Of These Regulations, Influencing Market Dynamics. CiteTurn0News18
At-Home Testing Demand: There'S A Growing Preference For At-Home Diagnostic Tests Due To Their Convenience And Accessibility. This Shift Is Prompting Companies To Develop User-Friendly, Reliable Home Testing Kits. CiteTurn0Search1
Integration With Healthcare Systems: Effective Integration Of Poc Diagnostics Into Existing Healthcare Infrastructures Is Crucial. This Includes Ensuring Interoperability With Electronic Health Records And Facilitating Seamless Data Sharing Among Healthcare Providers.
Scalability And Flexibility: The Industry Must Be Prepared To Scale Testing Capacities Rapidly In Response To Emerging Infectious Diseases, As Demonstrated By Labcorp'S Readiness To Increase Mpox Testing Capacity. CiteTurn0News20
**Personal Experience With Poc Diagnostics**
In My Experience, The Evolution Of Poc Diagnostics Has Been Remarkable. The Shift From Traditional Laboratory Settings To Bedside Or At-Home Testing Has Not Only Expedited Diagnosis But Also Empowered Patients To Take Charge Of Their Health. For Instance, During The Recent Health Crises, Having Access To Reliable At-Home Testing Kits Provided Peace Of Mind And Facilitated Timely Medical Interventions.
**Future Outlook**
The U.S. Poc Infectious Disease Diagnostics Market Is Poised For Continued Growth, With Projections Estimating An Increase From Usd 1.9 Billion In 2023 To Usd 4.59 Billion By 2033, Reflecting A Compound Annual Growth Rate (Cagr) Of Over 9.30%. CiteTurn0Search0 This Anticipated Expansion Underscores The Industry'S Commitment To Innovation And Meeting The Evolving Needs Of Healthcare Providers And Patients Alike.
In Conclusion, The Poc Infectious Disease Diagnostics Market In The U.S. Is Characterized By Diverse Diagnostic Technologies And Evolving Industry Requirements. As The Landscape Continues To Change, Staying Informed About These Developments Is Essential For Stakeholders Across The Healthcare Spectrum.
Get an In-Depth Research Analysis of the US Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Â
Thermo Fisher Scientific
Alere
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Point-Of-Care Infectious Disease Diagnostics Market
Immunoassays
Molecular Diagnostics
Microbial Culture
DNA/RNA Tests
Bioanalytical Devices
Rapid Testing
Laboratory Testing
Colloidal Gold-based Tests
Nucleic Acid Amplification Tests (NAAT)
HIV
Hepatitis
Influenza
COVID-19
Tuberculosis
Malaria
Sexually Transmitted Infections (STIs)
Hospitals
Diagnostic Laboratories
Clinics
Home Care Settings
Research Institutions
Direct Sales
Distributor Sales
Online Sales
Point-of-Care Distributors
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-Of-Care Infectious Disease Diagnostics Market Research Analysis
1. Introduction of the US Point-Of-Care Infectious Disease Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Point-Of-Care Infectious Disease Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Point-Of-Care Infectious Disease Diagnostics Market, By Type
6. US Point-Of-Care Infectious Disease Diagnostics Market, By Application
7. US Point-Of-Care Infectious Disease Diagnostics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Point-Of-Care Infectious Disease Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/